Lupus Erythematosus, Systemic: all 1,222 studies
Page 1 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.
- MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)Not yet recruitingNCT07892651
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesNot yet recruitingNCT07873931Phase 1
- Effectiveness of Resonance Frequency Breathing Exercises in Patients With Systemic Lupus Erythematosus and Central SensitizationNot yet recruitingNCT07868289Not applicable
- Subclinical Gastrointestinal Involvement in Juvenile Systemic Lupus ErythematosusNot yet recruitingNCT07858461
- CD19 CAR-T Therapy for Refractory Childhood-Onset Systemic Lupus ErythematosusRecruitingNCT07855302Phase 1
- The Primary Objective of the Trial is to Evaluate the Effect of the Addition of Belantamab Mafodotin to Standard of Care Therapy on the Titres of Serum Anti-dsDNA Antibodies in Patients With Previously Treated SLE.Not yet recruitingNCT07844200Phase 2
- A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestations Of Lupus With Or Without Systemic Disease [Elowen-LTE]Not yet recruitingNCT07840287Phase 3
- Diastolic Dysfunction and Inflammatory Biomarkers in Lupus NephritisNot yet recruitingNCT07837544
- F182112 Phase Ib Clinical Study for the Treatment of Patients With Systemic Lupus ErythematosusRecruitingNCT07829614Phase 1
- Pain Phenotyping of Rheumatic Diseases - An Observational StudyNot yet recruitingNCT07829497
- HEALTH Home Urinalysis TestingRecruitingNCT07823478Not applicable
- Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic PatientsNot yet recruitingNCT07810569
- Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic Lupus ErythematosusNot yet recruitingNCT07805863
- FT839 in Autoimmune DiseasesRecruitingNCT07800871Phase 1/2
- Study to Evaluate the Safety and Preliminary Efficacy of CD19 CAR-T Cell Therapy (TranspoCART19) in Patients With Refractory Lupus NephritisRecruitingNCT07799116Phase 1/2
- Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study CompletersNot yet recruitingNCT07791199Phase 3
- A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune DiseasesNot yet recruitingNCT07782450Phase 1/2
- SII and SIRI as Prognostic Biomarkers in Lupus NephritisNot yet recruitingNCT07780045
- A Study to Test CRT-402 in Refractory Autoimmune DiseaseRecruitingNCT07778446Phase 1/2
- Pain-Sleep in Rheumatic DiseaseNot yet recruitingNCT07775612Not applicable
- Clinical Utility of Serum Ribonuclease 1(RNASE1) as a Biomarker of Lupus Nephritis.Not yet recruitingNCT07763821
- Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and PrednisoloneRecruitingNCT07760480Phase 4
- A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusNot yet recruitingNCT07760155Phase 2
- A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus ErythematosusRecruitingNCT07751848Phase 3
- A Study of QLS2404 Injection in Healthy Participants and Participants With Rheumatic Autoimmune DiseasesNot yet recruitingNCT07751315Phase 1
- SNC116 Therapy for Refractory Systemic Lupus ErythematosusNot yet recruitingNCT07748156Early Phase 1
- A Study of ATG-201 in Adult Participants With Autoimmune DiseasesNot yet recruitingNCT07732309Phase 1
- C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Lupus Nephritis Refractory to Standard TherapyNot yet recruitingNCT07729826Phase 2
- Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II TrialNot yet recruitingNCT07721363Phase 2
- Effect of Melatonin Administration on Systemic Lupus Erythematosus PatientsNot yet recruitingNCT07721324Phase 2/3
- Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupus ErythematosusEnrolling by invitationNCT07720310
- Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)RecruitingNCT07719140Phase 4
- Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)Not yet recruitingNCT07688980Phase 1
- Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile LupusNot yet recruitingNCT07680010Not applicable
- Study on Early Visual Dysfunction in Patients With Systemic Lupus ErythematosusEnrolling by invitationNCT07679776
- A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyNot yet recruitingNCT07676266Phase 1
- RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune DiseasesNot yet recruitingNCT07674147Early Phase 1
- Biomarker Development for Autoimmune Disorders Involving the KidneysRecruitingNCT07666711
- CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus ErythematosusNot yet recruitingNCT07659704Phase 1/2
- Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune ThrombocytopeniaRecruitingNCT07657793Phase 2/3
- A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the BodyRecruitingNCT07649265Phase 1
- Reduced Vaccine Response to HZ/su in SLERecruitingNCT07636044
- A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus ErythematosusRecruitingNCT07630714Phase 2
- Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)RecruitingNCT07629596Early Phase 1
- To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus NephritisRecruitingNCT07629583Phase 1
- The Effect of Exercise on Cognitive Functions in Individuals With Systemic Lupus ErythematosusNot yet recruitingNCT07622251Not applicable
- IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT07617740Early Phase 1
- Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)RecruitingNCT07611747Phase 4
- A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)RecruitingNCT07607964Phase 1
- A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus NephritisRecruitingNCT07598396Phase 2
- CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune DiseasesNot yet recruitingNCT07596680Early Phase 1
- Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)RecruitingNCT07575347
- A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisRecruitingNCT07570862Phase 2
- Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune DiseasesRecruitingNCT07558850Not applicable
- Mediterranean Diet and Gut Microbiota in Children With Systemic Lupus ErythematosusNot yet recruitingNCT07555626Not applicable
- Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic DiseasesNot yet recruitingNCT07544225Phase 1
- A Clinica Study of SCTC21C in Participants With Systemic Lupus ErythematosusNot yet recruitingNCT07538154Phase 1/2
- MTS109 in Patients With Refractory Autoimmune DiseasesRecruitingNCT07526350Early Phase 1
- SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory LupusRecruitingNCT07523542Phase 1/2
- Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune DiseasesNot yet recruitingNCT07523282Phase 1
- CHT105 for the Treatment of Refractory Lupus NephritisEnrolling by invitationNCT07517536Not applicable
- First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and PharmacodynamicsNot yet recruitingNCT07516639Phase 1
- Immun4Cure Cohort of Autoimmune DiseasesRecruitingNCT07515638
- A Study of E6742 in Participants With Systemic Lupus ErythematosusRecruitingNCT07515014Phase 2
- Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus ErythematosusNot yet recruitingNCT07512947Phase 1
- A Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus ErythematosusRecruitingNCT07509892Phase 2
- Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus NephritisNot yet recruitingNCT07493655Not applicable
- Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT07490275Phase 1
- Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic DiseasesRecruitingNCT07490041Early Phase 1
- Identification of Modifiable Sleep-related Factors in Patients With Systemic Lupus Erythematosus.Not yet recruitingNCT07483541
- IASO-782 in Systemic Lupus ErythematosusRecruitingNCT07483346Phase 1
- Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune DiseasesRecruitingNCT07470151Not applicable
- To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus ErythematosusRecruitingNCT07447986Phase 2
- A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus ErythematosusRecruitingNCT07444307Phase 1
- YTS109 in Pediatric Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT07439029Phase 1
- A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus ErythematosusRecruitingNCT07438496Phase 3
- CD19 CAR T-Cell Therapy for Refractory Systemic Lupus ErythematosusRecruitingNCT07432334Phase 1
- Saphnelo Use in Females of Child-bearing PotentialNot yet recruitingNCT07431775
- A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusRecruitingNCT07430306Phase 3
- Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric LupusRecruitingNCT07425730
- NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine CareRecruitingNCT07424261
- A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune DiseasesRecruitingNCT07413341Phase 1
- A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)RecruitingNCT07409181Phase 2
- Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..Not yet recruitingNCT07408908Phase 1
- A Phase 3 Clinical Study of MIL62 in Systemic Lupus ErythematosusRecruitingNCT07405970Phase 3
- Study of CD19 CAR-T Therapy for Refractory SLERecruitingNCT07403097Phase 1
- " TREX1 Gene Mutations and Their Role in Systemic Lupus ErythematosusRecruitingNCT07397728
- The Effect of Clinical Pilates Training on Fatigue, Emotional State, Functional Capacity, Sleep and Quality of Life in Women With Systemic Lupus ErythematosusEnrolling by invitationNCT07394361Not applicable
- Omega-3 Supplementation in Systemic Lupus ErythematosusNot yet recruitingNCT07393399Not applicable
- A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)RecruitingNCT07371468Phase 1
- Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus ErythematosusNot yet recruitingNCT07364396Phase 1/2
- A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)RecruitingNCT07363590Phase 1
- A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)RecruitingNCT07355218Phase 3
- Immune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTERecruitingNCT07352332
- It is an Observational Study That Compare Prognosis of Typical and Atypical Systemic Lupus Erythematosus PresentationNot yet recruitingNCT07350772
- Hypnotherapy for Needle-related Procedural Pain and Anxiety Management in a Pediatric SettingNot yet recruitingNCT07349667Not applicable
- A Study of GR1803 in Systemic Lupus ErythematosusRecruitingNCT07348055Phase 1/2
- The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil TreatmentRecruitingNCT07340463Phase 2
- A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus ErythematosusRecruitingNCT07339332Early Phase 1
- A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseaseRecruitingNCT07332481Phase 3